Navigation Links
Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
Date:11/4/2007

15) and reflects Daiichi Sankyo's and Lilly's current beliefs. However, as with any pharmaceutical compound under development, there are substantial risks and uncertainties in the process of development and regulatory review. There is no guarantee that the compound will receive regulatory approval, that the regulatory approval will be for the indication(s) anticipated by the companies, or that later studies and patient experience will be consistent with study findings to date. There is also no guarantee that the compound will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission and Daiichi Sankyo's filings with the Tokyo Stock Exchange. Daiichi Sankyo and Lilly undertake no duty to update forward- looking statements.

Plavix(R)/Iscover(R) are registered trademarks of Sanofi-Synthelabo Inc.

P-LLY

1 American Heart Association. Heart Disease and Stroke Statistics - 2007

Update. Dallas, TX. American Heart Association. (Pg. 12)

2 World Health Organization. The Atlas of Heart Disease and Stroke - Types

of cardiovascular disease, 2005.

3 American Heart Association. Heart Disease and Stroke Statistics - 2006

Update. Dallas, TX. American Heart Association.

4 Bertrand CURE study

5 American Heart Association. Heart Disease and Stroke Statistics - 2007

Update. Dallas, TX. American Heart Association. (Pg. 10)

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. OHSU Researchers Announce New Discovery
5. PM announces a new health care order for India
6. Partnership Between Diabetes India And Elsevier Announced
7. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Tibet Announces the Dalai Lama’s Tour of South Americ
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:'I Count(TM): 10 Simple Steps to a Healthy Life': Time and Money-Strapped Americans Find Balance, Better Health with New Book 2Health News:'I Count(TM): 10 Simple Steps to a Healthy Life': Time and Money-Strapped Americans Find Balance, Better Health with New Book 3Health News:Joint Replacement Soars as Number of Docs Falls 2Health News:Joint Replacement Soars as Number of Docs Falls 3Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 2Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 3Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 4Health News:Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting 2Health News:Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting 3Health News:Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting 4Health News:Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting 5Health News:Apollo Health Street Has Earned the Number One Spot in the BPO Healthcare Providers Segment in the Prestigious Black Book of Outsourcing Customer Satisfaction Survey, 2008 2Health News:Shengtai Pharmaceutical, Inc. Comments On Its Operations 2Health News:Shengtai Pharmaceutical, Inc. Comments On Its Operations 3
Breaking Medicine Technology:BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Breast Abnormality Follow Up Often Later in Black Women 60080 1Breast Abnormality Follow Up Often Later in Black Women 60080 2Big Beefy Football Players May Face Heart Problems Later 60078 1Big Beefy Football Players May Face Heart Problems Later 60078 2Big Beefy Football Players May Face Heart Problems Later 60078 3Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 1Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 2Safety Management Services Inc Develops New Regional Preparation Course And Exam For CHEP Certification 60076 3